Timberlyne Therapeutics logo

Timberlyne Therapeutics Funding & Investors

San Diego, CA

Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.

timberlyne-tx.com

Total Amount Raised: $180,000,000

Timberlyne Therapeutics Funding Rounds

  • Series A

    $180,000,000

    Series A Investors

    Abingworth
    Bain Capital Life Sciences
    Venrock Healthcare Capital Partners
    3H Health Investment
    Lilly Asia Ventures
    Braidwell
    Boyu Capital
Funding info provided by Diffbot.